Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Stenhus Fastigheter i Norden AB (publ) in connection with their uplisting to Nasdaq Stockholm
Mandate

Vinge has advised Stenhus Fastigheter i Norden AB in connection with their uplisting to Nasdaq Stockholm

December 20, 2024 Capital Markets and Public M&A Corporate Tax Banking and Finance Corporate Crime & Compliance Employment and Benefits Environmental Law IT, Telecommunications and Outsourcing Real Estate and Construction

Vinge has advised Stenhus Fastigheter i Norden AB (publ) (“Stenhus Fastigheter” or the “Company”) in connection with the Company's uplisting to Nasdaq Stockholm. The first day of trading on Nasdaq Stockholm was 18 December 2024.

Stenhus Fastigheter is a real estate company that owns and manages public properties and commercial properties with a clear geographic focus on urban areas and growth cities. Stenhus Fastigheter also works actively with existing and potential building rights within the current portfolio.

Vinge’s team consisted mainly of Rikard Lindahl, Joel Magnusson and Michaela Ådén (Capital Markets and Public M&A), Diana Kanold (VDR), Victor Ericsson, Emelie Svanberg, Marcus Svärd and Ellenor Eckerborn (Tax), Nicklas Thorgerzon and Siri Blomberg (IT och GDPR), Ebba Svenburg and Jonna Skog (Employment), Kristoffer Larson, Madelene Andersson and Sara Franson (Real Estate), Lina Österberg (Environment), Ida Redander, August Ahlin and William Carlberg Johansson (Banking and Finance) and Hayaat Ibrahim and Jonna Fransson (Compliance).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025